Proton pump inhibitors linked to bone health risk

wordle featuring osteoporosis concepts
Researchers are urging caution in prescribing proton pump inhibitors, one of the world’s most commonly-issued drug groups, citing links to increased fracture risks in older Australian women. University of Queensland researchers led a study on proton pump inhibitors: Professor Susan Tett from the School of Pharmacy – one of three UQ schools involved in the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous HIV diagnoses stabilise, treatment uptake strong
Next Stakeholders call for action on alcohol promotion